Glucagon-like peptide-1 (GLP-1) analogs have emerged as a compelling therapeutic target for managing metabolic conditions. These naturally occurring molecules are secreted by the gut in response to meal intake, https://growthbookmarks.com/story20409712/unveiling-the-therapeutic-potential-of-glp-1-peptides